• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对6,7-二甲氧基-1,2,3,4-四氢异喹啉部分进行解构,以在P-糖蛋白(P-gp)/σ2受体混合剂中将P-糖蛋白(P-gp)活性与σ2受体亲和力分离。

Deconstruction of 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline moiety to separate P-glycoprotein (P-gp) activity from σ2 receptor affinity in mixed P-gp/σ2 receptor agents.

作者信息

Pati Maria Laura, Abate Carmen, Contino Marialessandra, Ferorelli Savina, Luisi Renzo, Carroccia Laura, Niso Mauro, Berardi Francesco

机构信息

Dipartimento di Farmacia-Scienze del Farmaco, Università degli Studi di Bari Aldo Moro, Via Orabona 4, I-70125 Bari, Italy.

Dipartimento di Farmacia-Scienze del Farmaco, Università degli Studi di Bari Aldo Moro, Via Orabona 4, I-70125 Bari, Italy.

出版信息

Eur J Med Chem. 2015 Jan 7;89:691-700. doi: 10.1016/j.ejmech.2014.11.001. Epub 2014 Nov 4.

DOI:10.1016/j.ejmech.2014.11.001
PMID:25462276
Abstract

6,7-Dimethoxytetrahydroisoquinoline is widely used as basic moiety in σ2 receptor ligands, in order to provide σ2versus σ1 selectivity. This same moiety is also widely exploited in modulators of P-glycoprotein (P-gp) efflux pump, so that mixed σ2/P-gp agents are often obtained. Deconstruction of 6,7-dimethoxytetrahydroisoquinoline moiety present in the potent mixed σ2/P-gp agent 6,7-dimethoxy-2-[4-[1-(4-fluorophenyl)-1H-indol-3-yl]butyl]-1,2,3,4-tetrahydroisoquinoline (1) could lead to the separation of σ2 affinity from P-gp activity. Therefore, phenethylamino-, benzylamino- and indanamine series were obtained. The NH group was also methylated in the N-phenethylamino series, and ethylated in the benzylamino series, to better match 6,7-dimethoxytetrahydroisoquinoline. The σ2 affinity drastically decreased with the increase of conformational freedom, whereas alkylation of the NH-group was beneficial for σ2 receptor interaction. By contrast, deconstruction of 6,7-dimethoxytetrahydroisoquinoline slightly reduced P-gp activity, with dimethoxy-substituted derivatives displaying potent P-gp interaction. Therefore, 'ring-opened' 6,7-dimethoxytetrahydroisoquinoline derivatives represent a promising strategy to obtain P-gp selective agents devoid of σ2 receptor affinity.

摘要

6,7-二甲氧基四氢异喹啉作为σ2受体配体的基本部分被广泛应用,以实现σ2对σ1的选择性。同一部分在P-糖蛋白(P-gp)外排泵调节剂中也被广泛应用,因此常常得到σ2/P-gp混合型药物。对强效σ2/P-gp混合型药物6,7-二甲氧基-2-[4-[1-(4-氟苯基)-1H-吲哚-3-基]丁基]-1,2,3,4-四氢异喹啉(1)中存在的6,7-二甲氧基四氢异喹啉部分进行解构,可能会将σ2亲和力与P-gp活性分离。因此,得到了苯乙胺基、苄胺基和茚胺系列。在N-苯乙胺系列中,NH基团也进行了甲基化,在苄胺系列中进行了乙基化以更好地匹配6,7-二甲氧基四氢异喹啉。随着构象自由度的增加,σ2亲和力急剧下降,而NH基团的烷基化有利于与σ2受体相互作用。相比之下,6,7-二甲氧基四氢异喹啉的解构略微降低了P-gp活性,二甲氧基取代的衍生物显示出强效的P-gp相互作用。因此,“开环”的6,7-二甲氧基四氢异喹啉衍生物是获得缺乏σ2受体亲和力的P-gp选择性药物的一种有前景的策略。

相似文献

1
Deconstruction of 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline moiety to separate P-glycoprotein (P-gp) activity from σ2 receptor affinity in mixed P-gp/σ2 receptor agents.对6,7-二甲氧基-1,2,3,4-四氢异喹啉部分进行解构,以在P-糖蛋白(P-gp)/σ2受体混合剂中将P-糖蛋白(P-gp)活性与σ2受体亲和力分离。
Eur J Med Chem. 2015 Jan 7;89:691-700. doi: 10.1016/j.ejmech.2014.11.001. Epub 2014 Nov 4.
2
From mixed sigma-2 receptor/P-glycoprotein targeting agents to selective P-glycoprotein modulators: small structural changes address the mechanism of interaction at the efflux pump.从混合的σ-2受体/ P-糖蛋白靶向剂到选择性P-糖蛋白调节剂:微小的结构变化揭示了与外排泵相互作用的机制。
Eur J Med Chem. 2015 Jan 7;89:606-15. doi: 10.1016/j.ejmech.2014.10.082. Epub 2014 Oct 30.
3
Synthesis and in vitro evaluation of tetrahydroisoquinolines with pendent aromatics as sigma-2 (σ2) selective ligands.合成及含并环芳烃的四氢异喹啉类化合物作为σ2(σ2)选择性配体的体外评价。
Org Biomol Chem. 2014 Feb 7;12(5):783-94. doi: 10.1039/c3ob42254b. Epub 2013 Dec 5.
4
Arylamides hybrids of two high-affinity σ2 receptor ligands as tools for the development of PET radiotracers.两种高亲和力 σ2 受体配体的芳酰胺杂合体作为 PET 放射性示踪剂开发的工具。
Eur J Med Chem. 2011 Sep;46(9):4733-41. doi: 10.1016/j.ejmech.2011.05.057. Epub 2011 May 30.
5
4-Biphenyl and 2-naphthyl substituted 6,7-dimethoxytetrahydroisoquinoline derivatives as potent P-gp modulators.作为强效P-糖蛋白调节剂的4-联苯和2-萘基取代的6,7-二甲氧基四氢异喹啉衍生物
Bioorg Med Chem. 2008 Apr 1;16(7):3732-43. doi: 10.1016/j.bmc.2008.01.055. Epub 2008 Feb 2.
6
Substituted benzylaminoalkylindoles with preference for the sigma2 binding site.优先作用于sigma2结合位点的取代苄基氨基烷基吲哚类化合物。
Eur J Med Chem. 2008 Oct;43(10):2073-81. doi: 10.1016/j.ejmech.2007.09.012. Epub 2007 Sep 26.
7
Small P-gp modulating molecules: SAR studies on tetrahydroisoquinoline derivatives.小P-糖蛋白调节分子:四氢异喹啉衍生物的构效关系研究
Bioorg Med Chem. 2008 Jan 1;16(1):362-73. doi: 10.1016/j.bmc.2007.09.039. Epub 2007 Sep 25.
8
Sigma-2 receptor agonists as possible antitumor agents in resistant tumors: hints for collateral sensitivity.Sigma-2 受体激动剂作为耐药肿瘤的潜在抗肿瘤药物:协同敏感性的提示。
ChemMedChem. 2013 Dec;8(12):2026-35. doi: 10.1002/cmdc.201300291. Epub 2013 Sep 19.
9
Synthesis of σ Receptor Ligands with a Spirocyclic System Connected with a Tetrahydroisoquinoline Moiety via Different Linkers.通过不同的连接子将具有与四氢异喹啉部分相连的螺环系统的σ 受体配体进行合成。
ChemMedChem. 2021 Apr 8;16(7):1184-1197. doi: 10.1002/cmdc.202000861. Epub 2021 Feb 2.
10
Synthesis and quantitative structure-activity relationships of N-(1-benzylpiperidin-4-yl)phenylacetamides and related analogues as potent and selective sigma1 receptor ligands.N-(1-苄基哌啶-4-基)苯乙酰胺及相关类似物作为强效和选择性σ1受体配体的合成与定量构效关系
J Med Chem. 1998 Jun 18;41(13):2361-70. doi: 10.1021/jm980032l.

引用本文的文献

1
The Tetrahydroisoquinoline Scaffold in ABC Transporter Inhibitors that Act as Multidrug Resistance (MDR) Reversers.作为多药耐药性(MDR)逆转剂的ABC转运蛋白抑制剂中的四氢异喹啉支架结构
Curr Top Med Chem. 2022;22(31):2535-2569. doi: 10.2174/1568026623666221025111528.
2
Novel Sigma-2 receptor ligand A011 overcomes MDR in adriamycin-resistant human breast cancer cells by modulating ABCB1 and ABCG2 transporter function.新型西格玛-2受体配体A011通过调节ABCB1和ABCG2转运蛋白功能克服阿霉素耐药人乳腺癌细胞中的多药耐药性。
Front Pharmacol. 2022 Aug 31;13:952980. doi: 10.3389/fphar.2022.952980. eCollection 2022.
3
Recent Progress Concerning the -Arylation of Indoles.
吲哚的 -芳基化反应的最新进展。
Molecules. 2021 Aug 22;26(16):5079. doi: 10.3390/molecules26165079.
4
σ Receptor and Its Role in Cancer with Focus on a MultiTarget Directed Ligand (MTDL) Approach.σ 受体及其在癌症中的作用,重点介绍一种多靶点定向配体 (MTDL) 方法。
Molecules. 2021 Jun 19;26(12):3743. doi: 10.3390/molecules26123743.
5
MRP1-Collateral Sensitizers as a Novel Therapeutic Approach in Resistant Cancer Therapy: An In Vitro and In Vivo Study in Lung Resistant Tumor.MRP1- 旁分泌敏化剂作为耐药性癌症治疗的新治疗方法:肺耐药肿瘤的体外和体内研究。
Int J Mol Sci. 2020 May 8;21(9):3333. doi: 10.3390/ijms21093333.
6
Targeting P-glycoprotein: Investigation of piperine analogs for overcoming drug resistance in cancer.靶向 P-糖蛋白:胡椒碱类似物克服癌症耐药性的研究。
Sci Rep. 2017 Aug 11;7(1):7972. doi: 10.1038/s41598-017-08062-2.